Treatment
HRS-1893 clinical trials
We’re tracking 4 recruiting studies that include HRS-1893, each written for real people, not researchers, below.
Recruiting studies
- NCT06816251RecruitingPhase 2
Study of HRS-1893 for non-obstructive hypertrophic cardiomyopathy
This trial tests a new medicine called HRS-1893 for people with a type of thick heart muscle disease that does not block blood flow. The goal is to see if it can improve symptoms or slow the condition.
Beijing, Beijing MunicipalityAges 18–85 - NCT07269717RecruitingPhase 2
Testing HRS-1893 for heart failure with preserved ejection fraction
This trial tests a new drug called HRS-1893 for people with heart failure with preserved ejection fraction (HFpEF). It aims to see if the drug can improve symptoms and quality of life.
Shanghai, Shanghai MunicipalityAges 40 years+ - NCT07021976RecruitingPhase 3
A study of HRS-1893 for obstructive hypertrophic cardiomyopathy
This trial tests an investigational drug called HRS-1893 in people with obstructive hypertrophic cardiomyopathy, a condition where the heart muscle is thickened and blocks blood flow. The study aims to see if the drug can improve symptoms and heart function.
Beijing, Beijing MunicipalityAges 18–85 - NCT07021963RecruitingPhase 2
Long-term safety study of HRS-1893 for hypertrophic cardiomyopathy
This study tests the long-term safety of the drug HRS-1893 in people with hypertrophic cardiomyopathy who have already been in a previous HRS-1893 study. It helps doctors learn more about how safe the drug is over time.
Beijing, Beijing MunicipalityAges 18–85
What HRS-1893 is being studied for
Conditions with recruiting HRS-1893 studies.
Common questions
- Are there clinical trials studying HRS-1893?
- Yes. Clin2 currently lists 4 recruiting studies that include HRS-1893, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a HRS-1893 trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is HRS-1893 an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether HRS-1893 or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.